432 related articles for article (PubMed ID: 32954917)
1. Degeneration of Bioprosthetic Heart Valves: Update 2020.
Kostyunin AE; Yuzhalin AE; Rezvova MA; Ovcharenko EA; Glushkova TV; Kutikhin AG
J Am Heart Assoc; 2020 Oct; 9(19):e018506. PubMed ID: 32954917
[TBL] [Abstract][Full Text] [Related]
2. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
[TBL] [Abstract][Full Text] [Related]
3. Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH.
Zhang R; Wang Y; Chen L; Wang R; Li C; Li X; Fang B; Ren X; Ruan M; Liu J; Xiong Q; Zhang L; Jin Y; Zhang M; Liu X; Li L; Chen Q; Pan D; Li R; Cooper DKC; Yang H; Dai Y
Acta Biomater; 2018 May; 72():196-205. PubMed ID: 29631050
[TBL] [Abstract][Full Text] [Related]
4. Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration.
Marro M; Kossar AP; Xue Y; Frasca A; Levy RJ; Ferrari G
J Am Heart Assoc; 2021 Feb; 10(3):e018921. PubMed ID: 33494616
[TBL] [Abstract][Full Text] [Related]
5. Mechanical versus bioprosthetic aortic valve replacement.
Head SJ; Çelik M; Kappetein AP
Eur Heart J; 2017 Jul; 38(28):2183-2191. PubMed ID: 28444168
[TBL] [Abstract][Full Text] [Related]
6. Porcine bioprosthetic heart valves: The next generation.
Manji RA; Menkis AH; Ekser B; Cooper DK
Am Heart J; 2012 Aug; 164(2):177-85. PubMed ID: 22877802
[TBL] [Abstract][Full Text] [Related]
7. Subclinical Structural Valve Degeneration in Young Patients With Bioprosthetic Aortic Valves.
Percy ED; Harloff M; Hirji S; Malarczyk A; Cherkasky O; Yazdchi F; McGurk S; Shekar P; Kaneko T
Ann Thorac Surg; 2021 May; 111(5):1486-1493. PubMed ID: 32979371
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure.
Kostyunin AE; Glushkova TV; Lobov AA; Ovcharenko EA; Zainullina BR; Bogdanov LA; Shishkova DK; Markova VE; Asanov MA; Mukhamadiyarov RA; Velikanova EA; Akentyeva TN; Rezvova MA; Stasev AN; Evtushenko AV; Barbarash LS; Kutikhin AG
J Am Heart Assoc; 2023 Jan; 12(1):e028215. PubMed ID: 36565196
[TBL] [Abstract][Full Text] [Related]
9. Do statins slow the process of calcification of aortic tissue valves?
Gilmanov D; Bevilacqua S; Mazzone A; Glauber M
Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):297-301. PubMed ID: 20570976
[TBL] [Abstract][Full Text] [Related]
10. Patient Risk Factors for Bioprosthetic Aortic Valve Degeneration: A Systematic Review and Meta-Analysis.
Ochi A; Cheng K; Zhao B; Hardikar AA; Negishi K
Heart Lung Circ; 2020 May; 29(5):668-678. PubMed ID: 31839362
[TBL] [Abstract][Full Text] [Related]
11. Age-related enhanced degeneration of bioprosthetic valves due to leaflet calcification, tissue crosslinking, and structural changes.
Xue Y; Kossar AP; Abramov A; Frasca A; Sun M; Zyablitskaya M; Paik D; Kalfa D; Della Barbera M; Thiene G; Kozaki S; Kawashima T; Gorman JH; Gorman RC; Gillespie MJ; Carreon CK; Sanders SP; Levy RJ; Ferrari G
Cardiovasc Res; 2023 Mar; 119(1):302-315. PubMed ID: 35020813
[TBL] [Abstract][Full Text] [Related]
12. A versatile modification strategy for functional non-glutaraldehyde cross-linked bioprosthetic heart valves with enhanced anticoagulant, anticalcification and endothelialization properties.
Yu T; Pu H; Chen X; Kong Q; Chen C; Li G; Jiang Q; Wang Y
Acta Biomater; 2023 Apr; 160():45-58. PubMed ID: 36764592
[TBL] [Abstract][Full Text] [Related]
13. Radical polymerization-crosslinking method for improving extracellular matrix stability in bioprosthetic heart valves with reduced potential for calcification and inflammatory response.
Guo G; Jin L; Jin W; Chen L; Lei Y; Wang Y
Acta Biomater; 2018 Dec; 82():44-55. PubMed ID: 30326277
[TBL] [Abstract][Full Text] [Related]
14. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants.
Johnston DR; Soltesz EG; Vakil N; Rajeswaran J; Roselli EE; Sabik JF; Smedira NG; Svensson LG; Lytle BW; Blackstone EH
Ann Thorac Surg; 2015 Apr; 99(4):1239-47. PubMed ID: 25662439
[TBL] [Abstract][Full Text] [Related]
15. National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements.
Isaacs AJ; Shuhaiber J; Salemi A; Isom OW; Sedrakyan A
J Thorac Cardiovasc Surg; 2015 May; 149(5):1262-9.e3. PubMed ID: 25791947
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of bioprosthetic aortic valve replacement in patients aged ≤60 years.
Anselmi A; Flecher E; Chabanne C; Ruggieri VG; Langanay T; Corbineau H; Leguerrier A; Verhoye JP
J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1534-1541.e4. PubMed ID: 28688707
[TBL] [Abstract][Full Text] [Related]
17. Mid-term follow-up in patients with Biocor porcine bioprostheses.
Bottio T; Rizzoli G; Gerosa G; Thiene G; Casarotto D
Cardiovasc Surg; 2002 Jun; 10(3):238-44. PubMed ID: 12044432
[TBL] [Abstract][Full Text] [Related]
18. Anticalcification strategies to increase bioprosthetic valve durability.
Thiene G; Valente M
J Heart Valve Dis; 2011 Jan; 20(1):37-44. PubMed ID: 21404896
[TBL] [Abstract][Full Text] [Related]
19. How to Decide Between a Bioprosthetic and Mechanical Valve.
David T
Can J Cardiol; 2021 Jul; 37(7):1121-1123. PubMed ID: 33002585
[TBL] [Abstract][Full Text] [Related]
20. Durability of Bioprosthetic Valves in Patients on Dialysis.
Uzuka T; Nakamura M; Sugiyama H; Kondo M; Sakata J
Ann Thorac Cardiovasc Surg; 2022 Oct; 28(5):334-341. PubMed ID: 35545525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
